The EBMT activity survey: 1990-2010

Bone Marrow Transplantation

Volumn 47, Issue 7, 2012, Pages 906-923

  Passweg, J R ^a   Baldomero, H ^a   Gratwohl, A ^a   Bregni, M ^b   Cesaro, S ^c   Dreger, P ^d   Witte, T De ^e   Farge Bancel, D ^f   Gaspar, B ^g   Marsh, J ^h   Mohty, M ⁱ   Peters, C ^j   Tichelli, A ^a   Velardi, A ^k   De Elvira, C Ruiz ^l   Falkenburg, F ^m   Sureda, A ⁿ   Madrigal, A ^o  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c Paediatric Haematology Oncology   (Italy)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f SAINT LOUIS HOSPITAL   (France)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

^h KING'S COLLEGE LONDON   (United Kingdom)

ⁱ NANTES UNIVERSITY HOSPITAL   (France)

^j ST ANNA CHILDREN S HOSPITAL   (Austria)

^k SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

^l GUY S HOSPITAL   (United Kingdom)

^m LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁿ ADDENBROOKE S HOSPITAL   (United Kingdom)

^o ANTHONY NOLAN RESEARCH INSTITUTE   (United Kingdom)

more..

Author keywords

donor; Europe; hematopoietic SCT; indications; stem cell source; transplant rates and trends

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; AUTOIMMUNE DISEASE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; BONE MARROW DEPRESSION; BREAST CANCER; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CORD BLOOD STEM CELL TRANSPLANTATION; DONOR; DONOR LYMPHOCYTE INFUSION; EUROPE; EWING SARCOMA; GERM CELL TUMOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBINOPATHY; HODGKIN DISEASE; HUMAN; IMMUNE DEFICIENCY; LEUKEMIA; LYMPHOPROLIFERATIVE DISEASE; MEDICAL SOCIETY; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NEUROBLASTOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; REVIEW; SOFT TISSUE SARCOMA; SOLID TUMOR; THALASSEMIA; TREATMENT INDICATION;

BONE MARROW TRANSPLANTATION; EUROPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; NEOPLASMS;

EID: 84863724732     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2012.66     Document Type: Review

References (23)

1. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med 2006; 354: 1813-1826.
2. Appelbaum FR. Hematopoietic-cell transplantation at 50. N Engl J Med 2007; 357: 1472-1475.
3. Gratwohl A, Schwendener A, Baldomero H, Gratwohl M, Apperley J Niederwieser D, Frauendorfer K. Changes in use of hematopoietic stem cell transplantation; a model for diffusion of medical technology. Haematologica 2010; 95: 637-643.
4. Gratwohl A, Baldomero H, Schwendener A, Gratwohl M, Apperley J, Frauendorfer K, Niederwieser D. The EBMT activity survey 2008 impact of team size, team density and new trends. Bone Marrow Transplant 2011; 46: 174-191.
5. Gratwohl A, Baldomero H, Horisberger B, Schmid C, Passweg J, Urbano-Ispizua A. Accreditation Committee of the European Group for Blood and Marrow Transplantation (EBMT). Current trends in haematopoietic stem cell transplantation in Europe. Blood 2002; 100: 2374-2386.
6. World Health Organisation, WHOhttp://www.who.int/topics/transplantation/ en/.
7. Yoshimi A, Suzuki R, Atsuta Y et al. Hematopoietic SCT activity in Asia: a report from the Asia-Pacific Blood and Marrow Transplantation Group. Bone Marrow Transplant 2010; 45: 1682-1691.
8. Gratwohl A. Bone marrow transplantation activity in Europe 1990. Report from the European Group for Bone Marrow Transplantation (EBMT). Bone Marrow Transplant 1991; 8: 197-201.
9. Gratwohl A, Baldomero H, Aljurf M, Pasquini MC, Bouzas LF, Yoshimi A et al. Hematopoietic stem cell transplantation: a global perspective. JAMA 2010; 303: 1617-1624.
10. Gratwohl A, Baldomero H, Schwendener A, Rocha V, Apperley J, Frauendorfer K et al. The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies. Bone Marrow Transplant 2009; 43: 275-291.
11. Gratwohl A, Baldomero H, Schwendener A, Gratwohl M, Apperley J, Niederwieser D et al. Joint Accreditation Committee of the International Society for Cellular Therapy; European Group for Blood and Marrow Transplantation; European Leukemia Net. Predictability of hematopoietic stem cell transplantation rates. Haematologica 2007; 92: 1679-1686.
12. Martin I, Baldomero H, Bocelli-Tyndall A, Slaper-Cortenbach I, Passweg J, Tyndall A. The survey on cellular and engineered tissue therapies in Europe in 2009. Tissue Eng Part A 2011; 17: 2221-2230.
13. Ljungman P, Bregni M, Brune M, Cornelissen J, deWitte T, Dini G et al. European Group for Blood and Marrow. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. Bone Marrow Transplantation 2010; 45: 219-234.
14. Chu R, Brazauskas R, Kan F, Bashey A, Bredeson C, Camitta B et al. Comparison of outcomes after transplantation of G-CSF stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemia. Biol Blood Marrow Transplant 2011; 17: 1018-1024.
15. Schrezenmeier H, Passweg JR, Marsh JC, Bacigalupo A, Bullorsky E et al. Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia. Blood 2007; 110: 1397-400.
16. Mehta P, Locatelli F, Stary J, Smith FO. Bone marrow transplantation for inherited bone marrow failure syndromes. Pediatr Clin North Am 2010; 57: 147-170.
17. Koreth J, Schlenk R, Kopecky KJ, Honda S, Sierra J, Djulbegovic BJ et al. Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials. JAMA 2009; 301: 2349-2361.
18. Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror ML, Boeckh M et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med 2010; 363: 2091-2101.
19. Kersey JH. The role of allogeneic-cell transplantation in leukemia. N Engl J Med 2010; 363: 2158-2159.
20. Meijer E, Cornelissen JJ. Allogeneic stem cell transplantation in acute myeloid leukemia in first or subsequent remission: weighing prognostic markers predicting relapse and risk factors for non-relapse mortality. Semin Oncol 2008; 35: 449-457.
21. Dreger P, Döhner H, Ritgen M, Böttcher S, Busch R, Dietrich S et al. German CLL Study Group. Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial. Blood 2010; 116: 2438-2447.
22. de Witte T, Hagemeijer A, Suciu S, Belhabri A, Delforge M, Kobbe G et al. Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial. Haematologica 2010; 95: 1754-1761.
23. Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant 2009; 15: 1628-1633.